Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.01 USD | -2.40% | +0.23% | -39.63% |
Apr. 26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
Apr. 26 | Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- TDOC Stock
- Revisions Teladoc Health, Inc.